NCT04806191

Brief Summary

Previous research suggests that general practitioners find handling patients with shoulder pain difficult and that the current care for shoulder pain is not in line with the best available evidence (1).This project aims to assess the effectiveness, costs and implementation of an evidence-based guideline for shoulder pain in general practice.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2021

Completed
8 days until next milestone

Study Start

First participant enrolled

March 11, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 19, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

November 3, 2022

Status Verified

November 1, 2022

Enrollment Period

2.2 years

First QC Date

March 3, 2021

Last Update Submit

November 1, 2022

Conditions

Keywords

General practiceImplementationGuideline

Outcome Measures

Primary Outcomes (1)

  • Change in Shoulder Pain and Disability Index (SPADI)

    13 item patient reported questionnaire on shoulder pain and disability. (0 = no pain or shoulder disability, 100 = worst pain and disability).

    Change from 0 to 12 weeks

Secondary Outcomes (3)

  • the EuroQol quality of life measure (EQ5D-5L)

    Change from 0 weeks to 52 weeks

  • Patient reported quality of care index (treatment according to the guideline intervention)

    0 week (after 1. visit to general practitioner)

  • Global patient perceived effect of treatment outcome (GPE)

    Measured at 6,12 and 52 weeks. Primary analysis of interest is at 12 weeks.

Other Outcomes (22)

  • Brief illness perception questionnaire (BIPQ)

    Measured at 0, 6, 12, 52 weeks, Primary time point of interest is 12 weeks and analysing changescore from 0 to 12 weeks.

  • Pain self-efficacy questionnaire (PSEQ)

    Measured at 0, 6, 12, 52 weeks, primary time point of interest is 12 weeks analysing change score from 0 to 12 weeks.

  • Work disability patient reported

    Measured at 0, 6, 12, 52 weeks

  • +19 more other outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Patients will be assessed by GPs who have attended an outreach workshop and trained at using an evidence based strategy for shoulder examination and treatment. GPs will have access to a decision support tool and patients is offered a tailored information package for self management.

Other: Evidence based treatment strategyOther: Targeted patient information package

Treatment as usual (TAU)

ACTIVE COMPARATOR

The participants enrolled in the control period will receive treatment as offered in general practice.

Other: Treatment as usual (TAU)

Interventions

Evidence-based clinical examination and treatment plan

Intervention

GPs will in cooperation with the patients tailor a information package targeted to the patients needs regarding their clinical shoulder diagnosis and individual implications and needs (Pain, sleep, exercises etc.).

Intervention

Usual care as provided by the GP

Treatment as usual (TAU)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pain in the shoulder region
  • Above 18 years

You may not qualify if:

  • Unable to fill in self-report questionnaires or do not understand Norwegian
  • Acute injury with clinical suspicion of fracture, luxation of shoulder joints or large tendon ruptures
  • Clinical suspicion of referred pain to the shoulder area from other organs
  • Signs of inflammatory joint disease
  • Suspicion of malignant disease
  • Symptoms and signs of cervical radiculopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Research and innovation, Helse Fonna, Norway

Haugesund, Vestland, 5504, Norway

RECRUITING

Department of General Practice, University of Oslo

Oslo, 0450, Norway

RECRUITING

Related Publications (3)

  • Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812.

    PMID: 22310560BACKGROUND
  • Artus M, van der Windt DA, Afolabi EK, Buchbinder R, Chesterton LS, Hall A, Roddy E, Foster NE. Management of shoulder pain by UK general practitioners (GPs): a national survey. BMJ Open. 2017 Jun 21;7(6):e015711. doi: 10.1136/bmjopen-2016-015711.

    PMID: 28637737BACKGROUND
  • Ekeberg OM, Pedersen SJ, Natvig B, Brox JI, Biringer EK, Endresen Reme S, Engebretsen KB, Joranger P, Mdala I, Juel NG. Making shoulder pain simple in general practice: implementing an evidence-based guideline for shoulder pain, protocol for a hybrid design stepped-wedge cluster randomised study (EASIER study). BMJ Open. 2022 Jan 7;12(1):e051656. doi: 10.1136/bmjopen-2021-051656.

MeSH Terms

Conditions

Shoulder PainBursitisRotator Cuff InjuriesMyalgiaShoulder Impingement SyndromeRupture

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsWounds and InjuriesShoulder InjuriesTendon InjuriesMuscular DiseasesNeuromuscular DiseasesNervous System DiseasesMusculoskeletal Pain

Study Officials

  • Niels G Juel, MD, PhD

    Department of General practice, University of Oslo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Stein J Pedersen, MD

CONTACT

Ole M Ekeberg, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessor will be blinded for treatment allocation. Randomization will be done after recruitment of GPs. GPs and study coordinators and outcome evaluators will be blinded to the allocation sequence with only the allocation of the next GP surgery being revealed by randomization list holder approximately 6 weeks before each intervention implementation point.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Model Details: Stepped wedge randomized study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD. PhD

Study Record Dates

First Submitted

March 3, 2021

First Posted

March 19, 2021

Study Start

March 11, 2021

Primary Completion

May 30, 2023

Study Completion

December 30, 2023

Last Updated

November 3, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations